3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
222
Liver Neoplasms
68
Neoplasms
18
Pancreatic Neoplasms
16
Neoplasm Metastasis
14
Colorectal Neoplasms
12
Rectal Neoplasms
8
Stomach Neoplasms
7
Colonic Neoplasms
7
Carcinoma, Renal Cell
6
Carcinoma
6
Liver Diseases
5
Gallbladder Neoplasms
5
Breast Neoplasms
5
Digestive System Neoplasms
4
Bile Duct Neoplasms
4
Prostatic Neoplasms
3
Kidney Neoplasms
3
Esophageal Neoplasms
3
Adenocarcinoma
3
Neoplasms, Glandular and Epithelial
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Multiple Myeloma
2
Melanoma
2
Hepatoblastoma
2
Hepatitis C
2
Hepatitis B
2
Hematologic Neoplasms
2
Glioblastoma
2
Interventions
Fluorouracil
67
Radiotherapy
53
Cisplatin
52
Oxaliplatin
47
Leucovorin
37
Paclitaxel
36
Irinotecan
27
Docetaxel
23
Capecitabine
20
Nivolumab
17
Carboplatin
16
pembrolizumab
15
Radiation
15
Neoadjuvant Therapy
15
Surgical Procedures, Operative
12
Cetuximab
12
durvalumab
9
Drug Therapy
9
Biopsy
9
Taxes
8
Folfox protocol
8
Chemotherapy, Adjuvant
8
Trastuzumab
7
Magnetic Resonance Spectroscopy
7
Gefitinib
7
Endoscopy
7
tremelimumab
6
Specimen Handling
6
Endoscopy, Digestive System
6
Ramucirumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Sorafenib
×
Gastrointestinal
×
Clear all
NCT01158287
2014-12-31
Sorafenib. ICORG 06-41, V4
Cancer Trials Ireland
Phase 2
Completed
54 enrolled